| John W Mcdonald, MD | |
|
1770 37th St, Vero Beach, FL 32960-4813 | |
| (772) 562-2929 | |
| (772) 562-2949 |
| Full Name | John W Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 48 Years |
| Location | 1770 37th St, Vero Beach, Florida |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043254964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME0039051 (Florida) | Primary |
| Entity Name | John W Mcdonald, Md, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255601498 PECOS PAC ID: 9133387525 Enrollment ID: O20120214000497 |
News Archive
Three major national databases include varying estimates of racial gaps in the use of immediate breast reconstruction (IBR) after mastectomy for breast cancer, reports a study in the March issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Control over obesity and diabetes may be one step closer thanks to a Hiroshima University study in fat tissue.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John W Mcdonald, MD 1770 37th St, Vero Beach, FL 32960-4813 Ph: (772) 562-2929 | John W Mcdonald, MD 1770 37th St, Vero Beach, FL 32960-4813 Ph: (772) 562-2929 |
News Archive
Three major national databases include varying estimates of racial gaps in the use of immediate breast reconstruction (IBR) after mastectomy for breast cancer, reports a study in the March issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced it signed a collaboration agreement with the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California. Under the terms of the agreement, HTG and JWCI (Department of Molecular Oncology, Dave S. B. Hoon, Ph.D., Director) will collaborate to generate a novel mRNA signature that can measure the gene expression differences in melanoma and benign nevi using HTG's qNPA technology in classical surgical pathology samples.
McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.
Control over obesity and diabetes may be one step closer thanks to a Hiroshima University study in fat tissue.
› Verified 4 days ago
Dr. Donald Proctor, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1325 36th St, Suite A, Vero Beach, FL 32960 Phone: 772-567-1164 Fax: 772-770-0799 | |
Dr. Elise Weinrich Geary, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1955 22nd Ave, Vero Beach Dermatology, Vero Beach, FL 32960 Phone: 772-299-0085 Fax: 772-978-4193 | |
Mr. Jonathan Sanders, MD JD Dermatology Medicare: Medicare Enrolled Practice Location: 1155 35th Ln, Suite 202, Vero Beach, FL 32960 Phone: 772-778-7782 Fax: 772-778-7879 | |
Patrick Thomas Ottuso, M D F A A D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1955 22nd Ave, Vero Beach, FL 32960 Phone: 772-299-0085 Fax: 772-978-4193 | |
Monika Srivastava, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1600 36th St Ste B, Vero Beach, FL 32960 Phone: 772-567-1164 Fax: 772-567-1501 | |
Neil S. Heskel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 865 37th Pl, Vero Beach, FL 32960 Phone: 772-567-4445 Fax: 772-567-8445 |